Filter
4110
Text search:
drug
strategy
Featured
Recommendations
369
New Publications
1146
Language
Document type
No document type
2428
Studies & Reports
687
Guidelines
511
Manuals
175
Strategic & Response Plan
174
Fact sheets
50
Training Material
49
Situation Updates
18
Infographics
11
Resource Platforms
5
Brochures
2
Countries / Regions
India
205
Global
162
Kenya
131
Uganda
106
South Africa
104
Ethiopia
102
Western and Central Europe
89
Nigeria
86
Nepal
80
Liberia
76
Sierra Leone
71
Malawi
71
Latin America and the Carribbean
71
Tanzania
70
Zambia
67
Myanmar / Burma
66
Africa
66
Bangladesh
58
Ghana
57
Rwanda
50
Namibia
47
Eastern Europe
44
Philippines
37
Ukraine
37
Asia
37
Cambodia
36
South–East Asia Region
33
Zimbabwe
31
Lesotho
28
Indonesia
24
Botswana
24
Russia
21
Syria
19
Mozambique
18
Colombia
18
Congo, Democratic Republic of
17
Senegal
16
Brazil
14
East and Southern Africa
14
Burkina Faso
13
Eswatini/ Swaziland
13
West and Central Africa
13
South Sudan
11
Thailand
11
Middle East and North Africa
11
Eastern Europe and Central Asia
10
Albania
10
Cameroon
9
Pakistan
9
Sudan
9
Venezuela
9
Vietnam
9
Guinea
8
Haiti
8
Western Pacific Region
8
Tajikistan
8
Georgia
8
USA
7
Germany
7
Peru
7
Laos
7
Afghanistan
6
China
6
Argentina
6
Sri Lanka
5
North America
5
Jordan
4
Benin
4
North Macedonia
4
El Salvador
4
Yemen
4
Timor Leste/ East Timor
4
Moldova
4
Iran
4
Somalia
3
Iraq
3
Lebanon
3
Turkey
3
Central African Republic
3
Honduras
3
Bolivia
3
Mexico
3
Paraguay
3
Bhutan
3
Jamaica
3
Mali
2
Morocco
2
Papua New Guinea
2
Switzerland
2
Hungary
2
Guatemala
2
Madagascar
2
Nicaragua
2
Southern Africa
2
Estonia
2
Uzbekistan
2
Kyrgyzstan
2
United Kingdom
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Chad
1
Gambia
1
Ireland
1
Dominican Republic
1
Austria
1
Serbia
1
Greece
1
Libya
1
Chile
1
Poland
1
Palestine
1
North Korea
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Kazakhstan
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1662
Clinical Guidelines
341
Public Health
232
Women & Child Health
138
Key Resources
119
Capacity Building
57
Pharmacy & Technologies
40
Annual Report MEDBOX
1
Toolboxes
HIV
499
TB
435
Mental Health
299
AMR
204
NTDs
202
COVID-19
152
NCDs
94
Malaria
92
Pharmacy
89
Caregiver
66
Planetary Health
55
Rapid Response
53
Ebola & Marburg
52
Global Health Education
46
Disability
45
Conflict
45
Refugee
40
Health Financing Toolbox
39
2.0 Rapid Response
23
Polio
21
Cholera
14
Natural Hazards
13
Specific Hazards
11
Zika
10
Social Ethics
7
Training for Health Care Providers
Facilitators’ Manual
Accessed Febr. 6, 2020
Accessed Febr. 6, 2020
Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrugresistant pathogens, and incr
...
ຢາຕ້ານເຊື້ອຈຸລະຊີບ (Antimicrobial medicines) ມີຄວາມສໍາຄັນຫຼາຍຕໍ່ວຽກງານການແພດ, ສາທາລະນະສຸກ, ສຸຂະພາບສັດ ແລະ ການຜະລິດອາຫານ. ເນ
...
4th Edition 2018
National Malaria Elimination & Aedes Transmitted Disease Control Program
Disease Control Unit Directorate General of Health Services
Improvements in water sanitation and hygiene (WASH) and wastewater management in all sectors are critical elements of preventing infections and reducing the spread of antimicrobial resistance (AMR) as identified in the Global Action Plan to combat AMR. Yet, at present, WASH and wastewater management
...
Saúde Soc. São Paulo, v.30, n.1, e200450, 2021
Desde março de 2020, quando a Organização Mundial de Saúde declarou que o mundo vivia uma pandemia de covid-19, acompanhamos um quadro sanitário sem precedentes nos últimos 100 anos. As medidas atuais contra a
...
16.7.2021
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian
...
scientific brief, 2 March 2022
Participant Modules
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il
...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease. Endemic in 21 Latin American countries, the disease can be transmitted by vector insects called triatomines — also known as “kissing bugs” —, foods or beverages contaminated with th
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
Forests, trees and green spaces, hereinafter ‘forests and trees’ for short, provide multiple goods and services that contribute to human health. These include medicines, nutritious foods and other non-wood forest products (NWFPs). Globally, at least 3.5 billion people use NWFPs, including medici
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est
...